You must be a medical professional to view these pages!

Intended Use

BLEScath™ is intended for the administration of bovine lipid extract surfactant suspension using minimally invasive surfactant therapy (MIST) / less invasive surfactant administration (LISA) technique for rescue treatment of infants with Neonatal Respiratory Distress Syndrome (NRDS/Hyaline Membrane Disease).

Este sitio web está registrado en wpml.org como sitio de desarrollo.